Showing results (51-60 of 125) with videos related to
Sort By:
Pageof 13
Pharmacoeconomics|January 6, 2000
Therapeutic options in the treatment of multiple myeloma: pharmacoeconomic and quality-of-life considerationsF Wisløff, N Gulbrandsen, E NordThrombosis Research|February 15, 1990
Comparison of methods for detecting soluble fibrin in plasma. An in vitro studyS Halvorsen, O H Skjønsberg, R Ruyter, et al.Thrombosis and Haemostasis|June 30, 1986
Binding of various thrombin fractions to fibrin and the influence of AT-III on their adsorptionD W Nilsen, F Brosstad, P Kierulf, et al.Thrombosis Research|November 7, 1998
Degradation of fibrinogen and cross-linked fibrin by human neutrophil elastase generates D-like fragments detected by ELISA but not latex D-dimer testE T Bach-Gansmo, H C Godal, O H SkjønsbergThrombosis Research|January 15, 1990
Quantitation of anticephalin antibodies in a computer-assisted enzyme-linked immunosorbent assay (ELISA): relation to lupus anticoagulantK E Sletnes, G Keirung, F WisløffTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 30, 1989
[Recurrence or therapeutic resistance of acute myelogenous leukemia. Effect of mitoxantrone and cytosine arabinoside]S A Evensen, L Brinch, F WisløffVox Sanguinis|January 1, 1986
Thrombin generation during collection and storage of bloodO H Skjønsberg, P Kierulf, M K Fagerhol, et al.Thrombosis Research|February 1, 1991
Shared idiotypic determinant in mono- and polyclonal anti-phospholipid antibodies with lupus anticoagulant activityF Wisløff, K E Sletnes, T MichaelsenThrombosis Research|April 1, 1992
Preparation of plasma for the detection of lupus anticoagulants and antiphospholipid antibodiesK E Sletnes, K Gravem, F WisløffPageof 13